Artificial Intelligence/Machine Learning Medical Device Global Market Report 2023: Sector is Expected to Reach $35.4 Billion by 2032 at a CAGR of 24.4% - ResearchAndMarkets.com

The "Artificial Intelligence/Machine Learning Medical Device Market - A Global and Regional Analysis: Focus on Product Type, Clinical Area, and Country Analysis - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

The global artificial intelligence/machine learning medical device market was valued at $4,011.7 million in 2022 and is anticipated to reach $35,458.2 million by 2032, witnessing a CAGR of 24.35% during the forecast period 2022-2032.

The market is driven by factors such as the presence of a large ecosystem of companies offering AI solutions, growing demand in the field of radiology and cardiology, growing demand for wearable sensors, and large number of government initiatives.

Market Lifecycle Stage

The global artificial intelligence/machine learning medical device market is highly fragmented, and the number of FDA and CE marked approvals of AI-enabled medical devices is increasing each year. This market still holds significant potential for growth as technological developments and investments into AI in healthcare are ongoing globally.

The opportunity for growth of the global artificial intelligence/machine learning medical device market lies in innovations in technology and the further development of AI-based medical devices enabling diagnostic accuracy and productivity.

Recent Developments in Global Artificial Intelligence/Machine Learning Medical Device Market

• In October 2022, Koninklijke Philips N.V. received the U.S. FDA 510(k) approval for its AI-enabled MRCAT head and neck radiotherapy application.
• In June 2022, Aidoc Medical, Ltd. raised a $110 million Series D round investment to address the challenges faced by health systems by using AI.
• In June 2022, Hyperfine Inc. received FDA 510(k) clearance for the MRI device Swoop. The Swoop system software uses deep learning to deliver clear images that aid in clinical diagnosis.
• In April 2022, Clarius Mobile Health Corp.'s range of ultra-portable scanners, Clarius HD, was approved by Health Canada.
• In March 2022, Clarius Mobile Health Corp. raised $20.0 million in funding to expand its commercial-scale activities.

Demand - Drivers and Limitations

The following are the drivers for the global artificial intelligence/machine learning medical device market:

• Presence of a Large Ecosystem of Companies Offering AI Solutions Targeting the Diverse Range of Applications of AI in the Healthcare
• Growing Demand in the Field of Radiology and Cardiology Increasing Adoption of AI-Enabled Solutions due to Their Ability to Shorten Waiting Times and Reduce Burden on Healthcare System
• Growing Demand for Wearable Sensors to Increase Adoption of AI-Enabled Medical Devices for Home-Based Care
• Large Number of Government Initiatives Advancing the Research and Development of AI-Enabled Medical Devices

The market is expected to face some limitations as well due to the following challenges:

• Lack of Transparency and Concerns around Data Sharing Leading to Cybersecurity Concerns and Hindering Adoption of AI in Healthcare
• Challenges Related to Identification and Minimization of Bias in AI Algorithms Leading to Concerns Surrounding the Reliability of Diagnosis and Thus Hindering the Use of AI-Enabled Solutions

Key Attributes:

Key Companies Profiled

• Aidoc Medical, Ltd.
• Canon Inc.
• CellaVision AB
• Clarius Mobile Health Corp.
• General Electric Company
• Hyperfine Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Nanox.AI Ltd.
• Paige.AI
• RadNet, Inc.
• Shanghai United Imaging Healthcare Co., Ltd.
• Siemens Healthineers AG
• Tempus
• Viz.ai, Inc.

Market Segmentation

Segmentation 1: by Product Type

• System/Hardware
• Software-as-a-Medical Device

The global artificial intelligence/machine learning medical device market (by product type) is expected to be dominated by the software-as-a-medical device segment.

Segmentation 2: by Clinical Area

• Radiology
• Cardiology
• Hematology
• Others

The global artificial intelligence/machine learning medical device market (by clinical area) is expected to be dominated by the radiology segment.

Segmentation 3: Radiology (by Type)

• Diagnostic Assistance
• Imaging
• Image Reconstruction
• Others

The global radiology artificial intelligence/machine learning medical device market (by type) is expected to be dominated by the diagnostic assistance segment.

Segmentation 4: Cardiology (by Type)

• Electrocardiography-Based Arrhythmia Detection
• Hemodynamics and Vital Signs Monitoring
• Others

The global cardiology artificial intelligence/machine learning medical device market (by type) is expected to be dominated by the electrocardiography-based arrhythmia detection segment.

Segmentation 5: by Region

• North America - U.S., Canada
• Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific - China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Rest-of-the-World - Brazil, Mexico, Israel, and Rest-of-Rest-of-the-World

The global artificial intelligence/machine learning medical device market (by region) is dominated by the North America region.

For more information about this report visit https://www.researchandmarkets.com/r/vstst3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230427005475/en/